Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis

Laboratory Investigation

Volumn 90, Issue 7, 2010, Pages 1024-1032

  Steib, Christian J ^a   Hartmann, Anna C ^a   Hesler, Christoph V ^a   Benesic, Andreas ^a   Hennenberg, Martin ^a   Bilzer, Manfred ^b   Gerbes, Alexander L ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Essex Pharma   (Germany)

Author keywords

bile duct ligation; Kupffer cell; leukotriene; portal pressure; thromboxane; TLR4

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; GADOLINIUM CHLORIDE; LEUKOTRIENE C4; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; SULOTROBAN; THROMBOXANE; TOLL LIKE RECEPTOR 4; TOMELUKAST; ZYMOSAN; CYSTEINE; CYSTEINYL-LEUKOTRIENE; LEUKOTRIENE; MYD88 PROTEIN, RAT; PEPTIDOLEUKOTRIENE; THROMBOXANE B2; TLR4 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; KUPFFER CELL; LIVER FIBROSIS; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; INFUSION; LIVER CIRRHOSIS; METABOLISM; PATHOPHYSIOLOGY; PERITONITIS; SPRAGUE DAWLEY RAT;

ANIMALS; CYSTEINE; HYPERTENSION, PORTAL; INFUSIONS, PARENTERAL; LEUKOTRIENES; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS; MALE; MYELOID DIFFERENTIATION FACTOR 88; PERITONITIS; PORTAL PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE B2; TOLL-LIKE RECEPTOR 4;

EID: 77954148997     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.60     Document Type: Article

References (35)

1. Moller S, Bendtsen F, Henriksen JH. Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis. Can J Gastroenterol 2001;15:94-106.
2. Wiest R, Tsai MH, Groszmann RJ. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats. Gastroenterology 2001;120:975-983.
3. Hennenberg M, Trebicka J, Stark C, et al. Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. Br J Pharmacol 2009;157:258-270.
4. Pinzani M, Vizzutti F. Fibrosis and cirrhosis reversibility: clinical features and implications. Clin Liver Dis 2008;12:901-913, x.
5. Miller AM, Masrorpour M, Klaus C, et al. LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver. J Hepatol 2007;46:276-285.
6. Steib CJ, Gerbes AL, Bystron M, et al. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2). J Hepatol 2007;47:228-238.
7. Graupera M, Garcia-Pagan JC, Titos E, et al. 5-Lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes. Gastroenterology 2002;122:387-393.
8. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002;35:478-491.
9. Bendtsen F, Krag A, Moller S. Treatment of acute variceal bleeding. Dig Liver Dis 2008;40:328-336.
10. Bernard B, Cadranel JF, Valla D, et al. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995;108:1828-1834.
11. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999;353:139-142.
12. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001;33:41-48.
13. Hou MC, Lin HC, Liu TT, et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 2004;39:746-753.
14. Steib CJ, Gerbes AL. Signaling pathways in liver diseases: Kupffer cells. In: Dufour J-F, Clavien P-A (eds). Signaling Pathways in Liver Diseases. Springer Verlag: Heidelberg, 2009.
15. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006;26:1175-1186.
16. Xu H, Korneszczuk K, Karaa A, et al. Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats. Am J Physiol Gastrointest Liver Physiol 2005;288:G277-G283.
17. Neugebauer H, Hartmann P, Krenn S, et al. Bacterial translocation increases phagocytic activity of polymorphonuclear leucocytes in portal hypertension: priming independent of liver cirrhosis. Liver Int 2008;28:1149-1157.
18. Garcia-Tsao G, Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 2004;18:353-372.
19. Hennenberg M, Trebicka J, Biecker E, et al. Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins. Hepatology 2007;45:495-506.
20. Bilzer M, Paumgartner G, Gerbes AL. Glutathione protects the rat liver against reperfusion injury after hypothermic preservation. Gastroenterology 1999;117:200-210.
21. Schauer RJ, Gerbes AL, Vonier D, et al. Induction of cellular resistance against Kupffer cell-derived oxidant stress: a novel concept of hepatoprotection by ischemic preconditioning. Hepatology 2003;37:286-295.
22. Bilzer M, Baron A, Schauer R, et al. Glutathione treatment protects the rat liver against injury after warm ischemia and Kupffer cell activation. Digestion 2002;66:49-57.
23. Tazi KA, Moreau R, Herve P, et al. Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling. Gastroenterology 2005;129:303-314.
24. Garcia-Tsao G, Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 2004;18:353-372.
25. Krohn N, Kapoor S, Enami Y, et al. Hepatocyte transplantation-induced liver inflammation is driven by cytokines-chemokines associated with neutrophils and Kupffer cells. Gastroenterology 2009;136: 1806-1817.
26. Tejima K, Arai M, Ikeda H, et al. Ischemic preconditioning protects hepatocytes via reactive oxygen species derived from Kupffer cells in rats. Gastroenterology 2004;127:1488-1496.
27. Joseph B, Malhi H, Bhargava KK, et al. Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology 2002;123:1677-1685.
28. Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007;13:1324-1332.
29. Uhrig A, Banafsche R, Kremer M, et al. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J Leukoc Biol 2005;77:626-633.
30. Guo J, Loke J, Zheng F, et al. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology 2009;49:960-968.
31. Zhou Q, Hennenberg M, Trebicka J, et al. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 2006;55:1296-1305.
32. Trebicka J, Hennenberg M, Laleman W, et al. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology 2007;46:242-253.
33. Yokoyama Y, Xu H, Kresge N, et al. Role of thromboxane A2 in early BDL-induced portal hypertension. Am J Physiol Gastrointest Liver Physiol 2003;284:G453-G460.
34. Katagiri H, Ito Y, Ito S, et al. TNF-alpha induces thromboxane receptor signaling-dependent microcirculatory dysfunction in mouse liver. Shock 2008;30:463-467.
35. Titos E, Claria J, Bataller R, et al. Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis. Gastroenterology 2000;119:794-805.